Newsroom | 36303 results

Sorted by: Latest

Medical Devices
-

MedX Announces Final Closing of Non-Brokered Private Placement

MISSISSAUGA, Ontario--(BUSINESS WIRE)--MedX Health Corp. (“MedX” or the “Company”) (TSX-V: MDX) is pleased to announce that, further to its Press Releases dated April 7, and May 22, 2025, announcing an Initial Closing and further Closing, it has completed a final Closing of the Non-brokered Private Placement to accredited investors originally announced in its Press Release dated February 25, 2025. The Final Closing comprised the issuance of 8,678,571 Units (as described below) and raised cash p...
-

Riassunto: La richiesta di revoca dell'esenzione per l'utilizzo del piombo di Butterfly Network passa alla fase di valutazione da parte degli stakeholder e dei consulenti

BURLINGTON, Massachusetts e NEW YORK--(BUSINESS WIRE)--Butterfly Network, Inc. ("Butterfly", "la Azienda") (NYSE: BFLY), un'azienda di sanità digitale che sta trasformando l'assistenza sanitaria con dispositivi portatili per ecografie per tutto il corpo, ha annunciato oggi che la Commissione europea ha ufficialmente avviato il periodo di revisione e consultazione delle parti interessate della richiesta dell'Azienda di revoca dell'allegato IV n. 14 della Direttiva RoHS della Commissione europea...
-

Resumen: Butterfly Network: Solicitud de revocación de la exención del plomo RoHS pasa a la etapa de evaluación de las partes interesadas y los consultores

BURLINGTON, Massachusetts y NUEVA YORK--(BUSINESS WIRE)--Butterfly Network, Inc. ("Butterfly", "la empresa") (NYSE: BFLY), empresa especializada en salud digital que transforma la atención médica con ultrasonidos portátiles de cuerpo entero, ha anunciado hoy que la Comisión Europea ha iniciado oficialmente el período de revisión y consulta de las partes interesadas para procesar la solicitud de la empresa de revocar el anexo IV n.º 14 de la Directiva sobre restricciones a la utilización de dete...
-

Samenvatting: Verzoek tot intrekking van RoHS-loodvrijstelling van Butterfly Network gaat naar beoordeling door belanghebbenden en consultants

BURLINGTON, Mass. & NEW YORK--(BUSINESS WIRE)--Butterfly Network, Inc. ('Butterfly', 'het bedrijf') (NYSE: BFLY), een digitaal gezondheidsbedrijf dat de zorg transformeert met draagbare echografie voor het hele lichaam, heeft vandaag aangekondigd dat de Europese Commissie officieel de periode voor beoordeling en consultatie met belanghebbenden heeft gestart voor het verzoek van het bedrijf tot intrekking van Bijlage IV nr. 14 van de RoHS-richtlijn (Restriction of Hazardous Substances) van de Eu...
-

Butterfly Network’s RoHS-Widerrufsantrag wegen Ausnahmeregelung für Blei tritt in die Phase Stakeholder-Konsultation und Beratung ein

BURLINGTON, Mass. & NEW YORK--(BUSINESS WIRE)--Butterfly Network, Inc. („Butterfly”, „das Unternehmen”) (NYSE: BFLY), ist ein Unternehmen für Digitalisierung des Gesundheitswesens, das die Pflege mit einem manuellen Ganzkörperultraschall transformiert. Es gab heute bekannt, dass die Europäische Kommission offiziell den Zeitraum für die Überprüfung und Konsultation der Stakeholder für den Antrag des Unternehmens auf Widerruf von Anhang IV n. 14 der Richtlinie „Restriction of Hazardous Substances...
-

La demande de révocation de l’exemption RoHS de Butterfly Network passe à l’étape de l’évaluation par les parties prenantes et les consultants

BURLINGTON, Massachusetts et NEW YORK--(BUSINESS WIRE)--Butterfly Network, Inc. (« Butterfly », « la société ») (NYSE : BFLY), une entreprise de santé numérique qui transforme les soins grâce à des échographes portables pour le corps entier, a annoncé aujourd’hui que la Commission européenne avait officiellement lancé la période d’examen et de consultation des parties prenantes concernant la demande de la société visant à révoquer l’annexe IV n° 14 de la directive RoHS (Restriction of Hazardous...
-

Somnics Health Launches iNAP Essentials: Making Innovative OSA Therapy Accessible for $58/Month

REDWOOD CITY, Calif.--(BUSINESS WIRE)--Somnics Health, a pioneer in next-generation sleep apnea solutions, announces the launch of iNAP Essentials, a breakthrough program giving patients access to iNAP Sleep Therapy for just $58/month over 24 months. This new initiative removes one of the biggest barriers to treatment—cost—and expands access to comfortable, mask-free therapy for patients with Obstructive Sleep Apnea (OSA). More than 50 million Americans suffer from OSA, yet 80% remain untreated...
-

Lubrizol Announces an Important Milestone for Its Novel Patented Excipient, Apisolex™ Polymer

CLEVELAND--(BUSINESS WIRE)--Lubrizol announces that an Apisolex™ polymer excipient-enabled drug formulation is in Phase 1 clinical trials. Introduced to the market in 2022, Apisolex polymer excipient is a polyamino acid-based polymer that enhances the solubility of BCS Class II and IV active pharmaceutical ingredients (API). Apisolex polymer excipient is manufactured following Good Manufacturing Practices (GMP) guidelines and can be used in dosage forms for various routes of administration, inc...
-

GE Appliances Opens Onsite Advanced Primary Care Clinic for Monogram Refrigeration LLC Employees and Families in Tennessee

SELMER, Tenn.--(BUSINESS WIRE)--America’s #1 Appliance Company1, GE Appliances, a Haier company, today announced the opening of a new onsite advanced primary care clinic at its Monogram Refrigeration LLC plant in Selmer, Tennessee. This state-of-the-art clinic will serve employees and their covered family members (age two and older), marking the first workplace-based health clinic of its kind in McNairy County. The new advanced primary care clinic is in addition to the traditional health covera...
-

Sesen Launches with a Singular Mission: Advancing Life Sciences Globally Through Specialized Language Solutions

BOSTON--(BUSINESS WIRE)--Today marks the official launch of Sesen, a next-generation language services company purpose-built to meet the complex demands of the life sciences industry. Specializing exclusively in translation, localization, and AI-enhanced linguistic solutions for pharmaceutical, biotechnology, medical device, CRO, and regulatory organizations, Sesen combines industry expertise with cutting-edge technology to deliver fast, accurate, and fully compliant multilingual communications...